Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

BSX

Boston Scientific (BSX)

Boston Scientific Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:BSX
DatumZeitQuelleÜberschriftSymbolFirma
24/04/202413h31IH Market NewsU.S. Futures Display Mixed Results Amid Earnings, WTI and Brent Crude Prices Dip in June Futures TradingNYSE:BSXBoston Scientific Corporation
24/04/202412h30PR Newswire (US)Boston Scientific Announces Results for First Quarter 2024NYSE:BSXBoston Scientific Corporation
08/04/202406h00PR Newswire (US)Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software ModuleNYSE:BSXBoston Scientific Corporation
01/04/202414h00PR Newswire (US)Boston Scientific Announces Conference Call Discussing First Quarter 2024 ResultsNYSE:BSXBoston Scientific Corporation
01/03/202412h55PR Newswire (US)Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated BalloonNYSE:BSXBoston Scientific Corporation
27/02/202422h15PR Newswire (US)Boston Scientific Announces Completion of €2.0 Billion Offering of Senior NotesNYSE:BSXBoston Scientific Corporation
23/02/202403h27PR Newswire (US)Boston Scientific Announces Pricing of €2.0 Billion of Senior NotesNYSE:BSXBoston Scientific Corporation
05/02/202414h00PR Newswire (US)Boston Scientific to Participate in TD Cowen's 44th Annual Health Care ConferenceNYSE:BSXBoston Scientific Corporation
31/01/202412h30PR Newswire (US)Boston Scientific Announces Results for Fourth Quarter and Full Year 2023NYSE:BSXBoston Scientific Corporation
31/01/202412h29IH Market NewsU.S. Futures Waver Ahead of Fed Decision Amid Mixed Corporate Earnings; Oil Prices SlideNYSE:BSXBoston Scientific Corporation
31/01/202412h25PR Newswire (US)Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation SystemNYSE:BSXBoston Scientific Corporation
08/01/202422h55PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.NYSE:BSXBoston Scientific Corporation
08/01/202417h36Dow Jones NewsAxonics Shares Climb 20% After Acquisition by Boston ScientificNYSE:BSXBoston Scientific Corporation
08/01/202413h41Dow Jones NewsBoston Scientific To Acquire Axonics For About $3.7 BillionNYSE:BSXBoston Scientific Corporation
08/01/202413h00PR Newswire (US)Boston Scientific Announces Agreement to Acquire Axonics, Inc.NYSE:BSXBoston Scientific Corporation
08/01/202413h00Business WireAxonics Announces Definitive Agreement to be Acquired by Boston ScientificNYSE:BSXBoston Scientific Corporation
05/01/202414h00PR Newswire (US)Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 ResultsNYSE:BSXBoston Scientific Corporation
28/12/202322h00PR Newswire (US)Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial FibrillationNYSE:BSXBoston Scientific Corporation
17/11/202315h00PR Newswire (US)Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.NYSE:BSXBoston Scientific Corporation
01/11/202313h00PR Newswire (US)Boston Scientific to Participate in Stifel's 2023 Healthcare ConferenceNYSE:BSXBoston Scientific Corporation
26/10/202312h30PR Newswire (US)BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER 2023NYSE:BSXBoston Scientific Corporation
25/10/202323h18AllPennyStocks.comMicrocap Offers Unique Opportunity for Investors In $10 Billion SCI IndustryNYSE:BSXBoston Scientific Corporation
25/10/202321h32Dow Jones NewsBoston Scientific Gets Positive Results for Heart-Failure DeviceNYSE:BSXBoston Scientific Corporation
25/10/202320h29PR Newswire (US)Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE TrialNYSE:BSXBoston Scientific Corporation
24/10/202321h18PR Newswire (US)REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS™ Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary EmbolismNYSE:BSXBoston Scientific Corporation
11/10/202317h19Dow Jones NewsBoston Scientific Down Over 6%, on Pace for Largest Percent Decrease Since May 2022 -- Data TalkNYSE:BSXBoston Scientific Corporation
02/10/202312h30PR Newswire (US)Boston Scientific Announces Conference Call Discussing Third Quarter 2023 ResultsNYSE:BSXBoston Scientific Corporation
21/09/202312h45PR Newswire (US)CVS Health appoints Michael F. Mahoney to its Board of DirectorsNYSE:BSXBoston Scientific Corporation
19/09/202313h45Dow Jones NewsBoston Scientific to Buy Relievant Medsystems for Initial $800 MillionNYSE:BSXBoston Scientific Corporation
19/09/202313h00PR Newswire (US)Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.NYSE:BSXBoston Scientific Corporation
 Showing the most relevant articles for your search:NYSE:BSX